Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Devon J Boyne"'
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 10 (2023)
Aim: The purpose of this retrospective, population-based, observational cohort analysis was to assess whether routine patient-reported outcomes (PRO) monitoring alone has an impact on real-world overall survival (OS) and hospitalizations among indi
Externí odkaz:
https://doaj.org/article/0eb0ab4a266643498f088ade8730d60f
Autor:
Devon J Boyne, Will D King, Darren R Brenner, John B McIntyre, Kerry S Courneya, Christine M Friedenreich
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198641 (2018)
Physical activity is associated with a lower risk of breast, colon, and endometrial cancer. Epigenetic mechanisms such as changes in DNA methylation may help to explain these protective effects. We assessed the impact of a one year aerobic exercise i
Externí odkaz:
https://doaj.org/article/a5d17a5c19a14de09f32a4929f12ac2f
Autor:
Amman Yusuf, Devon J. Boyne, Dylan E. O’Sullivan, Darren R. Brenner, Winson Y. Cheung, Imran Mirza, Tamer N. Jarada
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Laboratory data can provide great value to support research aimed at reducing the incidence, prolonging survival and enhancing outcomes of cancer. Data is characterized by the information it carries and the format it holds. Data c
Externí odkaz:
https://doaj.org/article/77ba153438d140d9b7e9a161a79c415b
Autor:
Dylan E. O’Sullivan, Devon J. Boyne, Chelsea Ford-Sahibzada, Jessica A. Inskip, Christopher J. Smith, Kaushik Sripada, Darren R. Brenner, Winson Y. Cheung
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 447-461 (2024)
The prognosis of early non-small-cell lung cancer (eNSCLC) remains poor. An understanding of current therapies and outcomes can provide insights into how novel therapies can be integrated into clinics. We conducted a large, retrospective, population-
Externí odkaz:
https://doaj.org/article/f9486525b3da431ea9bbe60f8f56da70
Autor:
Devon J. Boyne, Dylan E. O'Sullivan, Emily V. Heer, Robert J. Hilsden, Tolulope T. Sajobi, Winson Y. Cheung, Darren R. Brenner, Christine M. Friedenreich
Publikováno v:
Cancer Medicine, Vol 9, Iss 5, Pp 1613-1627 (2020)
Abstract Background Factors that are prognostic of early discontinuation of adjuvant chemotherapy among stage III colon cancer patients have yet to be described. To address this gap, a survey of medical oncologists and a systematic review and meta‐
Externí odkaz:
https://doaj.org/article/cb42d079707d49f5a946c39ae1b8a303
Autor:
Dylan E. O'Sullivan, Winson Y. Cheung, Devon J. Boyne, Tamer N. Jarada, Patricia A. Tang, Sharlene Gill, Robert J. Hilsden, Darren R. Brenner
Publikováno v:
Cancer Treatment and Research Communications, Vol 32, Iss , Pp 100585- (2022)
Background: The incidence of early-onset (
Externí odkaz:
https://doaj.org/article/0ccdfda1a5f34f1e9cf7da878bf7165e
Autor:
Vishal Navani, Daniel E. Meyers, Yibing Ruan, Devon J. Boyne, Dylan E. O'Sullivan, Samantha Dolter, Heidi AI Grosjean, Igor Stukalin, Daniel Y.C. Heng, Don G. Morris, Darren R. Brenner, Randeep Sangha, Winson Y. Cheung, Aliyah Pabani
Publikováno v:
Clinical Lung Cancer. 24:e152-e159
Publikováno v:
BMC Medical Research Methodology, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Several reviews have noted shortcomings regarding the quality and reporting of network meta-analyses (NMAs). We suspect that this issue may be partially attributable to limitations in current NMA software which do not readily prod
Externí odkaz:
https://doaj.org/article/02389a946cad4bfd933f0f7016499d2c
Autor:
Darren R, Brenner, Dylan E, O'Sullivan, Tamer N, Jarada, Amman, Yusuf, Devon J, Boyne, Cheryl A, Mather, Adrian, Box, Donald G, Morris, Winson Y, Cheung, Imran, Mirza
Publikováno v:
Lung Cancer. 175:60-67
While Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors have been shown to be effective in phase III randomized trials, the value of targeted therapies has been challenging to evaluate at the population-level. We examined the impact
Autor:
Dylan E. O’Sullivan, Tamer N. Jarada, Amman Yusuf, Leo (Xun Yang) Hu, Priyanka Gogna, Darren R. Brenner, Erica Abbie, Jennifer B. Rose, Kiefer Eaton, Julia Elia-Pacitti, Emmanuel M. Ewara, Aliyah Pabani, Winson Y. Cheung, Devon J. Boyne
Publikováno v:
Current Oncology; Volume 29; Issue 10; Pages: 7198-7208
Real-world evidence surrounding EGFR positive NSCLC patients in Canada is limited. Administrative databases in Alberta, Canada were used to evaluate EGFR testing and mutation prevalence in de novo metastatic NSCLC, as well as the characteristics, tre